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In 1908, Herter (1) first isolated the chromogen of the urorosein 
reaction (a red color with hydrochloric acid and nitrite) from urine 
and identified it as indoleacetic acid (IAA). The original identifi-
cation of.IAA as a growth factor for plants was made by Kogl et al. (2) 
on material isolated from human urine. Its formation in plants estab-
lished it as a substance of great metabolic consequence. The first 
indication of its origin was reported by Thimann (3), who found that 
tryptophan was needed in the medium of Rhizopus for auxin production. 
The existence in plants of enzymes (4, 5, 6) which form IAA from 
tryptophan has also been reported. In spite of the fact that the potent 
effect of this material on plant growth has been known for more than 
35 years, it is only since the rapid development of chromatographic 
and radiochemical techniques during the last fifteen years that 
increasing attention has been paid to the biochemistry of indole com-
pounds in plants, animals, and bacteria. Owing to the development of 
these techniques, a number of experiments have amply confirmed the view 
that tryptophan is the source of indoleacetic acid (IAA) in plants 
(7, 8), in animals (9, 10), and in bacteria (11, 12). 
In man, IAA and indoleaceturic acid have been observed as excre-
tory products in urine for many years. It has been generally assumed 
that these compounds were produced from tryptophan by the animals 1 
1 
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microbial flora (13). The IAA is derived from bacterial degradation of 
tryptophan in the gut and is then absorbed into the blood stream and to 
a large extent conjugated with glycine in the liver. Thus excretion 
can be. increased in the presence of an abnormal intestinal flora (13). 
However, it was found that intraperitoneal injection of DL-tryptophan-
7a-14c resulted in excretion of IAA-14c (9) and an enzyme system capable 
of converting L-tryptophan to IAA was observed in mammalian tissues 
(10}. These findings suggest that formation of IAA from tryptophan may 
be a normal metabolic pathway in mammals. 
It has also been reported that conversion of DL-tryptophan-7a-14c 
to IAA and indoleaceturic acid is greatly increased in vitamin B6-
deficiency in rats (9). A possible explanation for-this observation is 
that IAA is derived chiefly.from D-tryptophan and that vitamin 86-
defi ci ency interferes with the conversion of D-tryptophan to L-
tryptophan. 
This dissertation is concerned with studies designed to elucidate 
the mode of action of vitamin 86 on the production of IAA. The quanti-
tative and qualitative evaluation of the excreted indole compounds 
which are derived from D-tryptophan or L-tryptophan provide some. 
indirect evidence concerning the pathways involved in the metabolic 
interconversion of-indole compounds in mammals. The isolation of any· 
new metabolites of tryptophan from the urine of rats injected with 
tryptophan, using improved separation techniques, was also the purpose. 
of thi-s research. 
Since a satisfactory separation system was not available, this 
research was at first devoted to developing an.efficient column chroma-
tographic procedure for the separation of urinary indole and other 
tryptophan metabolites. A dual DEAE-cellulose column chromatography 
system using triethylamine-formate (TEA-F) buffer has been developed 




The Metabolism of D-tryptophan 
L-tryptophan can be converted to the DL-form by heating with baryt-
water at 150°c for 5-6 hours, or by acetyl ati on at room temperature. 
In 1933, Berg (14) isolated D-tryptophan from the quinine-salt of the 
DL-form in methanolic solution. Woods (15) reported that half as much 
indole was formed from DL- as from L-:tryptophan by Escherichia coli. 
Subsequently, Majima (16) obtained D-tryptophan from the DL-form using 
L coli o More recently D-tryptophan conjugated as N-malonyl-D-
tryptophan has also been isolated from a large number of fruits and 
vegetables (17)o The same nutritional effect of the D-isomer as the 
L-form in anima 1 s has been known for many years ( 18, 19). However, 
D-tryptophan has lower nutritional values than the corresponding L-
isomer (19, 20). D-tryptophan is not converted to indole by f. coli,· 
but can replace L-tryptophan in nutritional tests in animals. This 
suggests that the D- and L-isomers can be interconverted in animals.· 
In 1937, Kotake and Goto (21) found that f. coli can f9rm indole from 
some substance in the deproteinized supernatant of a reaction mixture 
containing D-tryptophan and liver homogenateo They suggested that D-
tryptophan is converted to the L-form in the liver. Also Behrman and 
Cullen (22) and Martin and Durham (23) have shown that D-tryptophan is 
converted by their bacterial preparations to L-tryptophan prior to 
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further metabolism. On the other hand, a metabolic pathway for D-
tryptophan that involves D-kynurenine has been suggested by studies in 
bacteria (24, 25), and in mammals (26, 27). However, Loh (28) has 
demonstrated that D-tryptophan can be either converted to D-kynurenine 
by enzymes specific for the D-isomer or be converted to 3~indolepyruvic 
acid and L-tryptophan and then to L-kynurenine in mammalian tissues. 
The enzyme which converts D-tryptophan to o.,~ynurenine was located in 
the soluble fraction of liver homogenate (29). 
Re.cently, Higuchi and Hayaishi (29) have summarized the significant 
differences between L-tryptophan pyrrolases and rabbit intestinal D-
isomer pyrrolase in their behavior toward the D- and L-enantiomorphs of. 
tryptophan. D-tryptophan pyrrolase activity was markedly inhibited by 
L-tryptophan, whereas L-tryptophan pyrrol ase was not inhibited by D-
tryptophan. D-isomer pyrrolase was capable of oxidation of L-
tryptophan at a limited rate, but the L-isomer pyrrolases of liver and 
bacteria were completely inactive with D-tryptophan a$ a substrate. 
Moreover, the conversion of D-tryptophan to D-kynureni ne requfred a 
formamidase reaction to hydrolyze the presumed intermediate compound, 
D-formylkynurenine, to yield D-kynurenine and fo.rmic acid. 
Biosynthesis and Metabolism of lndoleacetic Acid, lndole-3-
carboxaldehyde and Related Compounds 
lndoleacetic acid (IAA) is well known .as a metabolic product of 
tryptophan in plants, in microorganisms, and in animals. Yet the path-
ways of IAA biosynthesis and its metabolism in higher .and lower·plants 
are still incompletely understood. In animals, the pathway for IAA 
synthesis is even more obscure than in plants. 
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Since IAA is well established as a principal hormone of higher 
pl ants, the study of the biochemistry of IAA and related compounds has 
been carri.ed out extensively in the higher plants. In 1944, Larsen 
(30) reported the isolation and partial purification of a neutral 
indole compound with auxin activity from the tissues of pea, sunflower, 
and broadbean plants. From its chemical properties, he concluded that 
the substance was 3-indoleacetaldehyde. Evidence for the occurrence of 
this neutral compound in certain other plants was later provided by 
Hemberg (31) and by Gordon and Nieva (32, 33). More convincing proof 
of the presence of this substance in pea plants has been provided by 
Larsen and Aasheim (34). In 1953, another neutral indole compound, 
3-indoleacetonitrile, was found in cabbage plants by Henbest et al. 
(35). Larsen (36) demonstrated that exogenously supplied 3-indoleace-
taldehyde was converted to IAA by oat coleoptile tissue. Also Thimann 
(37) demonstrated the conversion of:a syntheti-c sample of·3-. 
indoleacetonitrile to IAA in several plant tissues. Recently, Moor 
and Shaner (38, 39) provided evidence that IAA is synthesized from 
tryptophan-14c in ce 11 free extracts of shoot tips of green pea seed-
1 i ng via indolepyruvate and indoleacetaldehyde. They demonstrated that 
the enzymic conversion of tryptophan-14c to IAA was enhanced by the 
addition of pyridoxal phosphate, a-ketoglutaric acid and thiamine 
pyrophosphate to reaction mixtures. The postulated intermediates, 
indolepyruvic acid-14c and indoleacetaldehyde-14c were also isolated 
from the cell-free reaction mixtures (38, 39). 
During studies of-indoleacetic acid in plants, it has been learned 
that plants infected by the vascular pathogen Pseudomonas solanacearum 
E. F. Smith manifest symptoms .associated with increased auxin content. 
The role of IAA in the development of these symptoms has been the sub-
ject of intensive study. In tobacco, it has been shown that the con-
centration of IAA in diseased tissues may be 100 times that in healthy 
tissues ( 40). It has been suggested that growth responses and changes 
in respiratory metabolism are due to hyperauxiny (40). 
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Due to the connection between pathogens and host plants, IAA has 
also been studied intensively in microorganisms. So far, the presence 
of a tryptophan transaminase in bacteria has been reported for f. coli 
( 41), Pseudomonas ( 44, 45) and Clos tri di um s porogenes ( 46) . Thus , the 
so-called indolepyruvate pathway receives frequent mention in bacterial 
systems, A large number of microorganisms appear to first deaminate 
tryptophan to indolepyruvic acid, which is then decarboxylated to 
indoleacetaldehyde (47, 48, 49, 50). In others, synthesis of IAA may 
proceed via 3-indoleacetamide (44, 51) or via decarboxylation of· 
tryptophan to tryptamine (52). 
In contrast with the flourishing studies of IAA in plants and in 
microorganisms, there have been few studies of IAA metabolism in ani-
mals. Although Werle and Mennicken (53) reported over thirty years 
ago that mammalian tissues can decarboxylate L-tryptophan, until 
recently few investigators regarded tryptamine as a normally occurring 
substance in tissues. Its presence in normal urine reported by 
Rodnight (54) in 1956, followed by the demonstration of tryptophan 
decarboxylation in animal tissues in 1959 by Weissbach et al. (10), has 
clearly established that tryptamine must be a normal constituent of 
animal tissues, and may be one of the int~rmediates in the formation of 
IAA from tryptophan. In animals, two metabolic pathways of tryptophan 
leading to IAA have been proposed (10); one via indolepyruvic acid, the 
other via tryptamine. However, the bulk of IAA probably arises from 
transamination, with only a smaller portion arising through decarboxy-
lation (10). 
IAA has been frequently found as conjugated compounds; as 
indoleacetyl aspartate in plants (55) and as indoleaceturic acid 
(glycine conjugate) in urine (13). Zenk (56) suggested that 
indoleacetyl-CoA was the intermediate in the.enzymatic formation of 
indoleacetyl-amino acid conjugate compounds. More recently, 
indoleacetyl-£-L-lysine was isolated from Pseudomonas savastanoi (57)~ 
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It has been known that IAA may be further metabolized to -other 
indole compounds. Some of the indole compounds found in plant materials 
undoubtedly come from IAA. Indole-3-carboxaldehyde has been reported 
as a product of the action of ultraviolet light on IAA (58, 59, 60). 
Another photochemical product of IAA was also. isolated and identified 
as indole-3-glycolic acid (58). Fischer (58) accordingly formulated 
the photo-oxidation of IAA as 
Indole-CH2-COOH --->- lndole-CHOH-COOH ---')- lndole-CO-COOH 
----> Indole-CHO 
An enzyme responsible for the oxidation of IAA has been found in a 
number of higher plants (61, 62,. 63, 64, 65) and fungi (66). Indole-3-
carboxaldehyde has been identified as the metabolic product of;this 
enzymatic reaction (61, 62, 63, 64, 65). Indole-3-carboxaldehyde has. 
also-been isolated in significant amounts.from human adrenal tumor 
tissue (67). More recently, Glombitza (68) has isolated this compound 
from yeast incubated with tryptophan, and Is kri c and Kveder. ( 69) 
reported this compound was formed from tryptamine in a rat liver 
preparation. 
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Finally, several pathways have been suggested for the conversion 
of tryptophan to IAA and the related indole compounds in plants (70), 
in microorganisms (51) and in animals (10). These pathways are shown in 
Figures 1, 2, and 3, respectively. 
Two Other Pathways Leading to Indole Compounds 
From Tryp toph an 
Fission to Indole 
There are at least four major metabolic pathways of tryptophan: 
(a) oxidation to formylkynurenine; (b) hydroxylation to 5-hydroxy-
tryptophan; (c) conversion to indoleacetic acid; (d) fission to indole, 
pyruvate and ammonia. Of these four pathways, three form indole com-
pounds from tryptophan. 
A quarter of a century ago, it was established that indole is 
produced by various bacteria such as f. coli, Vibrio Cholerae, 
Schigella dysenteri_ae, and by various species of Proteus. However, 
nothing was known about its precursors or its metabolism. Speculations 
were made on its formation, such as that tryptophan was converted to 
indole by step-wise removal of side chain carbons, one by one. However, 
in 1935, Happold (71) reported that indole was formed enzymatically from 
tryptophan by tryptophanase. It is now wel 1 known that tryptophanase 
is an enzyme which has pyridoxal phosphate as its coenzyme and cata-
lyzes the formation of indole from tryptophan according to the follow-
ing equation (72, 73, 74, 75). 
Figure 1. Possible Biochemical Pathways for the 
Formation of Simple Indole Compounds 
From Tryptophan in Plants. 
The pathways indicated with a solid arrow are 
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Figure 2, Possible Pathways for the Biosynthesis 
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Figure 3, Possible Pathways for the Biosynthesis 
of Indoleacetic Acid in Mammals. 





























Rec;ently, Mori no and Snell (76) have reported that tryptophanase of 
E. coli showed absolute requirements for pyridoxal phosphate and for 
K+ (or NH:) for activity. At room temperature and pH 800, the 
tryptophanase exists as a tetramer with a molecular weight of 220,000. 
Reversible di'ssociation of tryptophanp.se to a dimer occurs at low 
temperature or at room temperature in the presence of a very. low con-
centrations of sodium dodecyl sulfate. Ultracentrifugal measurements 
indicated the presence of four moles of pyridoxal phosphate per mole of 
holotryptophanase of mol, wt, 220,000. 
Further metabolism of indole has been observed in bacteria~ 
Sequential induction studies (77) have indicated that isatin, 
formylanthranilic acid, .anthranilic acid, salicylic acid, and catechol 
are formed from indoleo The .fate of indole in mammals is detoxication 
and excretion in the urine as the salt of the 0-sulfate of indoxyl, 
known as indican (77). Indole produces nausea, headache, and other 
unpleasant symptoms, whereas indican is harmless (78) and is a normal 
constituent of urine (79). 
Forrna ti on of Serotonin 
Tryptophan-5-hydroxylase is the enzyme transforming tryptophan into 
5-hydroxytryptophano In 1953 Udenfriend et al. (80) showed that DL .. 
tryptophan-2-14c was converted to labelled 5-hydroxytryptophan by liver 
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homogenates of rat and guine• pig. But Dalgliesh and-Dutton (81, 82) 
could not confirm the presence of the step, tryptophan----5-
hydroxytryptophan in vitro by using an isolated perfused mouse liver. 
However; there is .little doubt that a hydroxylation must occur in vivo, 
for the administration of labelled tryptophan results in the presence 
of labelled 5-hydroxyindoleacetic acid in the urine (83). This pathway 
which accounts for only 1% of the administered tryptophan in normal 
subjects, reaches about 60% in patients with carcinoid, a tumor of the 
intestinal argentaffin cell (83). · This finding suggested that the site 
where tryptophan was phys i o l ogi ca lly hydroxyl a ted was in the argentaffi n 
or.enterochromaffin cells of the intesti.ne (81, 84). 
The presence of .tryptophan hydroxyl ase in brain tissue has been 
repeatedly demonstrated by work..!..!!. vivo (85, 86, 87) and..!..!!. vitro (88, 
89, 90, 91). Peters et al. (92) reported that the distribution of 
tryptophan hydroxylase in cat brain roughly paralleils the distribution 
of s~rotonin. The most active areas were the caudate nucleus, septal 
area, anterior perforating substance, hypothalamus, amygdala and 
various areas of the midbrain. It has been suggested that tryptophan 
hydroxylase is the rate-controlling step in the biosynthesis of ._the 
neurotransmitter, serotonin, from L-tryptophan (93). 
An alternative hypo thesis has been considered, namely the poss i-
bility that tryptophan is first decarboxylated to yield tryptamine 
(94, 95, 96) and then tryptamine is hydroxylated to serotonin (97). 
However, it has been shown that tryptamine cannot be a precursor of· 
serotonin (98). 
5-Hydroxytryptophan decarboxylase is the enzyme which conver.ts 5-
hydroxytryptophan to 5-hydroxytryptamine (serotonin). When highly 
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purified, it is quite unstable and sensitive to changes of pH and 
temperature (99). The enzyme requires the presence of pyridoxal 
phosphate as cofactor. Pyridoxal phosphate may be replaced by 
pyridoxamine phosphate, but not by pyridoxine or pyridoxal (100). 5-
Hydroxytryptophan decarboxylase is widely distributed in nature. Mam-
malian kidney and liver are particularly rich in this enzyme which is 
present in the non-particulate fraction after ultracentrifugation (101). 
Foetal liver (102) and kidney (103) of rat contain less 5-hydroxy-
tryptophan decarboxylase activity than the respective adult tissues. 
Monoamine oxidase is an enzyme able to transform 5-hydroxytrypta-
mine into 5-hydroxyindoleacetaldehyde which is, in turn, converted to 
5~hydroxyindoleacetic acid (104, 105) by an aldehyde dehydrogenase 
(106, 107). A soluble preparation of monoamine oxidase has been ob-
tained by several methods (107, 108, 109). However, little is known 
about the structure and the requirements of this enzyme. The metabolic 
pathway for the formation of serotonin is shown in Figure 4. 
Vitamin-85-Deficiency and Its Effect on 
Tryptophan Metabolism 
Many species of experimental animals have been shown to develop 
deficiency symptoms when they are fed diets lacking pyridoxine. At 
first the changes are minimal, although in young animals a slightly 
slower growth rate can be detected, Later on there are dermatological 
changes on the exposed parts (paws and snout), with edema (rat); 
cessation of growth; elevated systolic blood pressure: appearance of a. 
peculiar gait: degenerative changes in peripheral nerves and pos-
terior roots (pig); lowered threshold to electroshock (rat); microcytic 
Figure 4. Possible Biochemical Pathways for the 
Formation of 5-Hydroxytryptamine 
(Serotonin) and 5-Hydroxyindoleacetic 
Aci d from Tryp toph an i n Mamma 1 s . 









NH 2 \ 
















anemia (pig, monkey); enlargement of the adrenal gland with marked 
changes in the microscopic appearance of the cortex; and eventually 
convulsions (110). All these symptoms respond to pyridoxine adminis-
tration. 
It is well known that a deficiency of vitamin 86 will alter the 
normal metabolism of tryptophan in such a manner as to lead to the 
excretion of. large amounts of xanthurenic acid in the urine. Therefore, . . / 
the appearance of abnornally high amounts of xanthurenic acid in the 
urine after a loading dose of tryptophan has been generally accepted as 
a reliable indication of vitamin 86-deficiency in man and in experimen-
tal animals. Vitamin 86 (pyridoxine) is required as a coenzyme in the 
catabolism of this amino acid at the stage of 3-hydroxykynurenine, 
where it plays a role in the scission of the side chain to yield 3-
hydroxyanthrani lic acid (action of kynureninase). Alternatively, 3-
hydroxykynurenine may be converted to the corresponding keto acid under 
the influence of another pyridoxal phosphate-linked enzyme, hydroxy-
kynurenine transaminase. This keto a.cid cyclizes spontaneously to form 
xanthurenic acid. Under conditions of vitamin 86-deficiency, 
kynureni nase apparently loses its coenzyme more readily than does the 
hydroxykynurenine transaminase (111), with the result that the balance 
of tryptophan breakdown is upset and abnormally lar~e amounts of. 
xanthureni c acid are excreted in the urine. Al so it has been reported 
that the vitamin 86-deficient animals excreted abnormally large quanti-
ties of kynureni ne, 3-hydroxykynureni ne and acetyl kynureni ne in addi -
tion to xanthurenic acid (112; 113, 114). 
Tissue levels of serotonin were found to be markedly diminished in 
vitamin 86-deficient animals, since vitamin 86 is a coenzyme for 
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5-hydroxytryptophan decarboxylase activity (115, 116). It was report~d 
that vitamin b6-deficiency decreased glycine, L-tryptophan and L-
methionine uptake into the cells of animals from a suspending fluid 
(117). 
CHAPTER I II 
METHODS AND·EXPERIMENTS 
Animal Experiments 
Male rats (Holtzman Co., Wisconsin) weighing 350-400 gm were 
injected intraperitoneally with D- or L-tryptophan (17 mg/100 gm of 
bodyweight) along with 10 µc D- or L-tryptophan-methylene-14c. Rats of 
s.imilar size were injected intraperitoneally with 3.5 mg/100 gm of 
indoleacetic acid along with 4.8 µc indoleacetic ac1d-2-14c for each 
rat. Vitamin s6~deficiency was obtained by feeding rats weighing 
approximately 100 gm with a vitamin 86-deficient diet for 5-15 weeks 
before use. Vitamin 86-deficient rats were injected with the same 
concentration of tryptophan orindol.eacetic acid as normal rats. 
Experiments utilizing germ-free rats were conducted by Dr. N. Raica at 
Fitzsimons .General Hospital, U, S. Army Medical Research and Nutrition 
Laboratory, Denver, Colorado. The urine of animals from these experi-
ments (urines of genn-free rats injected with D- or L-tryptophan-
methylene-14c) were lyophilized and shipped to the author for analysis. 
The experimen~al animals were transferred into an all-glass metab-
olism cage immediately after injection. Uri~e was collected from each 
rat for 24 hours in a vessel containing a.few drops of 0.5 N acetic 
acid and surrounded by dry ice. The urines were ftltered through 
sintered glass, lyophilized and stored at -20° C. The exhalation of 
14co2 from experimental germ-free rats was meas~red. 
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Chemical Synthesis of Indoleaceturic Acid 
Since indoleaceturic acid (indoleacetylglycine) is not available 
from a commercial source, it was synthesized according to the method of 
00 
Wieland and Horlein (118). 
Indoleacetic acid 1.76 gm and 1.4 ml triethylamine were dissolved 
in 30 ml of absolute tetrahydrofuran. The mixture was cooled too° C, 
and 0.96 ml of ethyl chloroformate was added dropwise with shaking. 
After 5 min, the glycine solution (750 mg glycine dissolved in 8 ml of 
1.25 M NaOH) was added to the reaction mixture. After standing at o° C 
for 30 min until it decolorized due to the decomposition of the anhy-
dride, the solution was brought to room temperature with shaking. The 
reaction mixture was evaporated under vacuum to remove the volatile 
components, and was acidified with 2 N HCl until it became cloudy 
(pH 3-4). A precipitated syrup became solid after scratching with a 
glass rod. The solid was filtered and washed with water to free.it 
from indoleacetic acid contamination. The purified solid was dissolved 
in warm water and formed a clear supernatant and a brown oily pre-
cipitate; the brown oily precipitate was removed by centrifugation and 
the clear supernatant was kept in the cold room until white needle 
crys ta 1 s formed. 
The complete separation of crystallized indoleaceturic acid from 
indoleacetic acid was accomplished by fractional crystallization. The 
crystals were dissolved in a minimum volume of ethyl acetate, after 
which, petroleum ether (40-80° C) was added dropwise until the solution 
became cloudy. The cloudy solution was stored in the cold room to 
precipitate crystals. This procedure was repeated twice. 
The purified crystals showed a M. P. of 86-88° C. The purity was 
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confirmed by paper chromatography (119, 120). After hydrolysis with 
0,5 N HCl at 100°c for one hour the substance showed a molar ratio of 
indoleacetic acid and glycine of 1:1. 
Column Chromatography 
Since a satisfactory column chromatographic separation of indole 
metabolites of tryptophan was not available, several types of columns, 
such as silica-gel (121)~. Amberlite IR-120 (pyridine form) (122), 
Sephadex G-25 (123), Sephadex G-10, DEAE-Sephadex A-25, Dowex-1 (for-
mate), Florisil and DEAE-cellulose, were investigated, A dual column of 
DEAE-cellulose chromatography system using triethylamine-formate 
(TEA-F) buffer as solvent was developed for this research. 
DEAE-cellulose was poured with stirring into a beaker containing 
about 20 volumes (volume liquid/dry weight exchanger) of 0.5 N HCl and 
left for 30 min. The supernatant liquid was decanted and the solid 
washed with deionized water until the supernatant solution was around 
pH 4.0. This supernatant was decanted and the resulting exchanger was 
poured into a beaker containing 5 volumes (volume liquid/swollen 
exchanger) of 0.5 N NaOH with gentle stirring and left for 30 min. The 
supernatant liquid was decanted and the solid was washed with deionized 
water until the supernatant liquid was around pH 9.0, The DEAE-
cellulose was then packed into a large column (5 x 75 cm) and eluted 
with deionized water until the effluent was neutral. This exchanger 
was used for DEAE-cellulose (amine-form) column chromatography. 
The DEAE-cellulose (amine form) in a large column (5 x 75 cm) was 
washed with 10 volumes of 1 M sodium formate and the excess sodium 
formate was washed out with deionized water. Then the column was 
treated with 0.001 M TEA-F of pH 4.0 until the exchanger was equili-
brated. This exchanger was used for the first DEAE-cellulose column 
chromatography (formate form). 
Several authentic tryptophan metabolites were loaded on a 1.2 x 
30 cm column of DEAE-cellulose (formate). The column was then eluted 
with 80 ml of pH 4.0, 0.001 M TEA-F (2 ml/fraction), followed by a 
linear gradient from 0.001 M to 0.1 M of the same buffer solution 
(4 ml/fraction) in 250 ml:250 ml. 
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The chromatogram is shown in Figure 5. The first two peaks 
(approximately 30 ml-60 ml) in Figure 5 contain several components. The 
fractions from the two peaks were combined and lyophilized. The lye-. 
philized material was dissolved in about 5-10 ml water and loaded on a 
second column of DEAE-cellulose (amine-form). This column was eluted 
with 140 ml pH 8.0, 0.001 M TEA-F·(2 ml/fraction), followed by a linear 
gradient from 0.001 M to 0.05 M of the same buffer solution in 200 ml : 
200 ml (4 ml/fraction). The column chromatogram is shown in Figure 6. 
Both columns were run in the cold at== 5oc. The recovery of the authen-
tic compounds was more than 95% from both DEAE-cellulose columns. 
Column chromatography for the separation of compounds in the crude 
urine samples was carried out using the same procedures as for the 
authentic compounds. To assure complete elution of all radioactive 
metabolites, a linear gradient from 0.1 M to 0.3 M of TEA-F, pH 4.0 
(4 ml/fraction) in 200 ml : 200 ml was used on the DEAE-cellulose-
formate column after the linear gradient from 0.001 M to 0.1 M TEA-F. 
Paper Chromatography 
Descending paper chromatography following the procedures of 
Figure 5. Separation of Tryptophan Metabolites 











_H 4.0 TEA""'.F .. t pH 4.0 TEA..;F 1 lllM(250ml) a 0.1 M(250ml). 4 ml each· 
















0 . 10 20 ;O 40 10 20 40 
















pH 8.0 TEA-F 1 mM -*- pH 8.o TEA-F 1 mM , 50 mM 
100 ~' 2 ml each 4 ml each, (200ml) (200ml) 
I-CN 
80 L I ~ ~ I-ald 
60 l ~;~21+ 11 11 Try OH-Try 
40 
I I I I ~ ' Kyn 
I I t 11 I I f 
20 







Dalgliesh (119) and Annstrong et al, (120) was employed as one of the 
techniques for isolation and identification of radioactive metabolites 
of tryptophan-methylene-14c and indoleacetic acid-2-14c. The location 
of various compounds was detected by chemical methods, such as 
Ehrlich's reagent (120), 2,4-dinitrophenylhydrazine (120), ninhydrin 
reagent (0.2% ninhydrin in 95% ethanol), by UV fluorescence and by 
detection of radioactivity on a Nuclear Chicago 4n strip counter. 
Colorimetry and Fluorimetry 
Quantitative and qualitative detennination of the authentic com-
pounds and the corresponding radioactive metabolites was carried out as. 
follows, 
Indoleacetic acid and indoleaceturic acid were detennined by the 
Gordon-Weber modification of the Salkowski's reagent (124) and 
Ehrlich's reagent (125). To one ml of aqueous solution, two ml of 
Salkowski's reagent (0,01 M ferric chloride in 35% of perchloric acid) 
was added with shaking. After standing for 50 min absorbance due to 
indoleacetic acid and indoleaceturic acid was determined at 530 mµ and 
550 mµ, respectively, on a Coleman Junior Spectrophotometer, In the 
other method, to one ml of aqueous solution, two ml of Ehrlich's 
reagent (10 gm of p-dimethylaminobenzaldehyde dissolved in 100 ml of 
cone hydrochloric acid) was added with shaking. The resulting violet 
color was read immediately at 550 mµ (both indoleacetic acid and 
indoleaceturic acid). 
Indole-3-carboxaldehyde was detennined by the method of Stutz 
(64). The sample solution was evaporated to dryness using a rotary 
evaporator. Absolute ethanol (2.5 ml) was added and to this ethanol 
solution was added 0.25 ml of 2,4-dinitrophenylhydrazine reagent (100 
mg of 2,4-dinitrophenylhydrazine in 100 ml of 6 N HCl). The colored 
solution was read immediately at 550 mµ, 
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Tryptophan, indoleacetonitrile, kynurenine and N-acetylkynurenine 
were determined by the Chen-Gholson modification of the N-1-naphthyl-
ethylenediamine dihydrochloride method (126). To a 2 ml aqueous solu-
tion were successively added: 0.2 ml of 2,5% sodium nitrite and 0.2 ml 
of oxidizing agent (mixture of 1 volume 60% perchloric acid and 4 vol-
umes cone sulfuric acid, the mixture diluted to double volume with 
water), 4 min later 0.2 ml of 10% ammonium sulfamate were added 
followed 4 min later by 0.2 ml of 0.25% N-1-napthylethylenediamine 
dihydrochloride. After standing 20 min (indoleacetonitrile) or one 
hour (tryptophan, kynurenine and N-acetylkynurenine) at room tempera-
ture, the colored solutions were read at 550 mµ (indoleacetoni.trile, 
kynurenine and N-acetylkynurenine) or 555 mµ (tryptophan). 
Tryptamine, serotonin and 5-hydroxytryptophan were determined by 
Ehrlich's reagent (125) as described in the indoleacetic acid determina-
tion. 
5-Hydroxindoleacetic acid was determined by the method of Ratliff 
(127). To 1 ml of aqueous sample solution was successively added: 
0.5 ml of 1-nitroso-2-naphthol (0.1% solution in 95% ethanol) and 0,5 
ml nitrous acid reagent (freshly prepared 2.5% sodium nitrite in water), 
20 min later 5 ml of ethylene chloride was added, the mixture stoppered 
and shaken for 1 min. After standing several min, the upper layer was 
pipetted off and was read at 540 mµ, 
3-Hydroxykynurenine and xanthurenic acid were determined according 
to the method of Coppini et al. (128). To 2 ml of aqueous sample 
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solution, 0.6 ml of diazotized sulfanilic acid (0.5% p-diazobenzene 
sulfonic acid in 2% hydrochloric acid, mixed before using with an equal 
volume of 0.5% sodium nitrite in water) and 0.12 ml of pyridine were 
added. The absorbancy due to xanthurenic acid was read immediately at 
510 mµ. The 3-hydroxykynurenine sample was read after 1 hour at 450 mµ. 
Xanthurenic acid was alternatively measured by adding an equal volume 
of 50% NaOH to the aqueous sample solution. After centrifuging tne 
sample was determined fluorometrically at 535 mµ (excitation 370 mµ} 
using an Aminco-Bowman Spectrophotofluorometer. 
Kynurenic acid was determined according to the method of Benassi 
et al. (122). To 1.5 ml aqueous sample solution, 1 ml of cone sul-
furic acid was added slowly while cooling with ice. After 15 min. the 
sample was read fluorometrically at 333 mµ excitation wavelength and 
440 mµ emission wavelength. 
Other Methods 
Each fraction eluted from the DEAE-cellulose column was monitored 
for radioactivity in a Packard Tri-Carb Liquid Scintillation Spec-
trometer by pipetting a 0.1 ml aliquot into 10 ml of scintillation 
fluid. The scintillation fluid was composed of 600 ml toluene, 400 ml 
ethanol, 4.0 gm of 2,5-diphenyl-oxazole and 0.2 gm of 1,4-bis [2-(5-
pheny1'oxazo lyl)J::-benzene (129). The quantitative measurement for ~ach 
metabolite was based primarily on the radioactivity determination. 
Each radioactive peak was measured for its absorption spectrum by using 
a Beckman DB Spectrophotometer. Subsequently, each radioactive peak 
was lyophilized and dissolved in a minimum volume of deionized water or 
acetone for its identification. 
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The new metabolite, indole-3-carboxaldehyde was crystalized by the 
method of Shaw 'and Rysen (130). The 2,4-dinitrophenylhydrazone was 
prepared (131) and the melting point was measured. Ultraviolet spectra 
at different pH's were measured by using a Beckman DB Spectrophotometer, 
Infrared spectra were determined using a Perkin-Elmer 457 Grating 
Infrared Spectrophotometer in KBr pellets prepared with a micro-
sampling kit, Mass spectra were determined with the prototype (132) of 
the LKB-900 gas chromatograph-mass spectrometer using a direct inlet 
probe, Melting points were determined with a Kofler Micro M, P, 
apparatus, 
Chemicals 
D- and L-tryptophan-methylene-14c and indole-3-acetic acid-2-14c 
were obtained from Nuclear Chicago Corp.; L-tryptophan, indole-3-acetic 
acid, kynurenic acid and xanthurenic acid from Sigma Chemical Co,; 
tryptamine hydrochloride, D-5-hydroxytryptophan, indole-3-carboxaldehyde 
and 5-hydroxyindoleacetic acid from Aldrich Chemical Co.; D-tryptophan 
and L-kynurenine sulfate from Calibiochem Laboratories. 3-Hydroxy-DL-
kynurenine was a gift from Dr, L, M, Henderson of the University of 
Minnesota, Minneapolis, Minnesota. Serotonin creatinine sulfate and 
indole-3-acetonitrile were purchased from K & K Laboratories. DEAE-
cellulose (Cellex-0) and Dowex-1 were purchased from Bio-Rad Laborator~ 
ies. DEAE-Sephadex A-25, Sephadex G-10 and Sephadex G-25 were pur-
chased from Pharmacia Fine Chemicals Inc Amberlite CG-120, silicic 
acid (100 mesh) were purchased from Mallinckrodt Chemical Works. 
Florisil (60-100 mesh) and p-dimethylaminobenzaldehyde were purchased 
from Fisher Scientific Co, 2,4-Dinitrophenylhydrazine, 
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N-1-naphthylethylenediamine dihydrochloride, ammonium sulfamate and 
1-nitroso-2-naphthol were obtained from Eastman Kodak Co. Vitamin 8-
complex test diet was obtained from Nutritional Biochemicals Corp, All 




Identification of the New Metabolite 
During the course of this study, a previously unreported urinary 
metabolite of tryptophan, indole-3-carboxaldehyde (I-ald), was isolated 
from the urines of normal, vitamin 86-deficient, germ-free and germ-
free vitamin 85-deficient rats following the intraperitoneal injection 
of O-tryptophan-methylene-14c. The isolation of this new metabolite 
from DEAE-cellulose columns is shown in Figures 11, 13, 15, and 18, 
The new metabolite was eluted in the 50 ml to 80 ml fractions of 
0,001 M effluent from the second column (DEAE-cellulose-amine form), 
The compound was tentatively identified as I-ald by ultraviolet spec-
trum, paper chromatography in 4 different sol.vent systems (119, 120), 
peak coincidence between radi oacti vi ty and colorimetric determination 
of the 2,4-dinitrophenylhydrazone, and by co-column chromatography with 
authentic I-aldo 
In order to further confirm this unknown compound as I-ald, the 
fractions containing this metabolite were combined then lyophilized and 
crystallized. The melting points of I-ald and its 2,4-dinitrophenyl-
hydrazone derivative were found to be 194-8°C and 273-8°C, respectively. 
A mixed melting point with an authentic sample of I-ald showed no 
depression. 
Figure 7.shows a comparison of the absorption spectra at different 
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Figure 7. Ultraviolet Sprectra of Authentic Indole-
3-carboxaldehyde and the Material 
Isolated from Rat Urine. 
--- = compound dissolve~ in H20; -·-·-·-··= · 
in O .1 N HCl; - - - - = ,n O. 1 N NaOH. 
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pH values of authentic I-ald and the urinary I-ald in the ultraviolet 
region. The concentration of the authentic compound was 4 ~M, and from 
the calculation based on radioactivity, the concentration of this new 
metabolite was 3.9 ~M. The change in the UV spectrum at pH 13.0 was 
interpreted (67) as being due to the following conversion: 
WCHO 
H 
__ a_l_k_a_l_i _____ ~ w CHOH 
Figure 8 shows the infrared absorption spectra for the urinary 
compound and authentic I-ald. The N-H stretching is characterized by a 
broad band between 3120 and 2900 CM- 1 in both spectra. The carbonyl 
stretching frequency occurs at 1631 cM-1. The similarity of these 
spectra is evident. 
The mass spectral fragmentation patterns for the unknown and 
authentic compounds are in excellent agreement as shown in Figure 9. 
Both show a base peak at 144, a parent peak at 145 and an indole frag-
ment at 116. An impurity in the purchased compound at mass 149 was 
observed, but it did not contribute significantly to the total ion 
production, 
From Table I, it is evident that I-ald is one of the major metab-
olites of D-tryptophan in the rat. This metabolite was not detected in 
the urine of rats injected with L-tryptophan. 
Figure 8. Infrared Spectra of Authentic Indole-3-
Carboxaldehyde and the Material 
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Figure 9. Mass Spectra of Authentic Indole-3-
Carboxaldehyde and the Material 
Isolated from Rat Urine. 
The spectra were computer plotted from tabular 










































































DISTRIBUTION OF RADIOACTIVITY AMONG METABOLITES IN 24-HOUR URINE 
SAMPLES OF NORMAL AND BG-DEFICIENT RATS FOLLOWING THE 
INTRAPERITONEAL INJECTION OF 17 MG/lOOG 
D-TRYPTOPHAN-METHYLENE- 14C (% OF DOSE) 
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Co2 output 
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Urinary Metabolites of D- and L-Tryptophan-Methylene-14c 
in Germ-Free and Normal Ra ts . 
Metabolites of D-Tryptophan in Bfi-Fed Animals 
The radioactive metabolites isolated from the urine;! of germ-free 
and normal rats injected with D-tryptophan-methylene-14c are shown in 
Figures 10 and 11 and Figures 12 and 13, respectively. 
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In the g~rm-free rat.--There are at least 12 radioactive metabo-
lites that have been isolated in this experiment (Figures 10 and 11). 
Nine of these metabolites have been identified, and are listed as 
follows: urea, I-ald, kynurenine (Kyn),.tryptophan (Try), N-acetyl-
kynurenine (N-A-Kyn), N-acetyl-3-hydroxykynurenine (N-A-OH-Kyn), IAA, 
indoleaceturic acid (I-gly) and kynurenic acid (K. A.). The quanti-
tative data are shown in Table I. IAA (7.8% of total dose) and its 
glycine conjugate, I-gly (5.0% of total dose) are the major urinary 
metabolites. The new metabolite, I-ald, was isolated but .in less 
quantity than that isolated from the urine of.the normal rat. N-A-Kyn 
and N-A-OH-Kyn were observed as the metabolites. of D- and L-tryptophan 
either in 85-fed or 85-deficient animals. Three metabolites, GFDle, 
GFDlf-and GFD6 have not been identified as yet. 
In the normal rat.--Seven.known metabolites have been isolated and 
identified as urea, Try, N-A-Kyn, N-A-OH-Kyn, IAA, I-gly, a trace of 
Kyn and a new metabolite identified as I-ald (Figures 12 and 13). The 
kynurenine was separated by paper chromatography in BuOH-HAc-H20 (4:1: 
5 by vol) and 20% (W/V) KCl, from the radio aGtive peak of I-ald shown 
in Figure 13. Urea, Try, IAA and I-gly are the major metabolites in 
this experiment. The quantitative data are shown in Table I. 
Figure 10. 
Figure 11. 
Separation of Urinary Tryptophan 
Metabolites of Germ-Free Rat Injected 
with D-Tryptophan-Methylene14C on the 
pH 4.0 DEAE-Cellulose Column. 
Rechromatography of Combined Fractions 
14-35 From the pH 4.0 Column (Figure 10) 
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Separation of Urinary Tryptophan 
Metabolites of Normal Rat Injected 
with D-Tryptophane-Methylene- 14C 
on the pH 4.0 DEAE-Cellulose Column. 
Rechromatography of Combined Fractions 
12-34 from the pH 4.0 Column (Figure 12) 
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Metabolites of D"".'Tryptophan 'in B6-Defici.ent Animals 
In the germ-free rat.--At least 14 metabolites were isolated as 
shown in Figures 14 and 15. Eleven of the metabolites were identified 
as urea, tryptamine (T-HH2), I-ald, Try, N-A-Kyn, N-A-OH .. kyn, IAA, 
I-gly, 3-hydroxykynurenine (OH-Kyn), K. A. and a trace of Kyn. T-NH2 
was isolated by the previously described paper chromatography method 
from the first peak of Figure 15. The substance, B6GFD10 (unknown I), 
shows a UV spectrum similar to that of xanthurenic acid (X. A.). After 
partial hydrolysis (hydrolysis in 0.5 N HCl at 1oooc for one hour) of 
this substance, a X. A. spot was detected by paper chromatography. The 
conjugate compound of X. A. was also isolated from the urines of L-
_tryptophan injected germ-free and normal rats under B6-depletion. The 
properties of this X. A. conjugate compound and authentic X. A. are 
given in Table II. A comparison of the UV spectra of the authentic 
X. A., urinary X; A. arid. the Unknown I (x~· A. conjugate: compound) ·is·. 
sliown in Figure 16. 
In 1960~ Baglioni et al. (134) isolated two metabolites from the 
urines of rats after administration of X. A. They identified them as 
X. A. conjugate compounds. The proposed structures are: 
OR 
I: R = S03H 
II : R = C6Hg06 
Substance I is a compound formed by X. A., glycine and sulfate. 
Its Rf is 0.14 in BuQH-HAc-H2o (4:1:5 by vol) and 0.47 in 20% (W/V) 
KCl. Substance II is a compound formed by X. A., glycine and glucuron-
ic acid with an Rf of 0.09 in BuOH-HAc-H 2o and 0.53 in 20% KCl. 
Figure 14. Separation of Urinary Tryptophan 
Metabolites of B6-Deficient Germ-
Free Rat Injectea with D-Tryptophan-
Methylene-14C on the pH 4.0 DEAE-
Cellulose Column. 
Figure 15. Rechromatography of Combined Fractions 
16-34 from the pH 4.0 Column (Figure 14) 
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TABLE II 
PROPERTIES OF URINARY CONJUGATE OF XANTHURENIC 
ACID AND AUTHENTIC XANTHURENIC ACID 
Rf in BuOH-HAc-H20# 
( 4: 1: 5 by VO 1) 
Rf in 20% (w/v) KCl 
Ehrlich's reagent test 
























#Dalgliesh (119) used the organic phase of BuOH-HAc-H20(4:1:5} for 
a solvent system. 
Figure 16. Absorption Spectra of Authentic Xanthur-
enic Acid, Urinary Xanthurenic Acid and 
Urinary Conjugate Compound of Xanthur-
enic Acid in pH 4.0 TEA-F Buffer. 
-- = authentic xanthureni c acid; -·-·- = uri-
nary xanthureni c acid; - - - - = urinary conju-
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The isolated compound, Unknown I (B6GFD10 of Figure 14, B6GFL8 of 
Figure 23, and B6LN7 of Figure 25) shows similarities to both Substance 
I and I I. The Rf va 1 ue of this Unknown I in the BuOH-HAc-H2o sys tern is 
0.10-0.13 and 0.48-0.54 in 20% KCl. Since it was only partially hydro-
lyzed and the quantity in the urine was sma 11, it was di ffi cult to 
detect sulfate, glycine and glucuronate residues in the hydrolysate. 
Further studies should be made of these residues. 
In this experiment, I-ald, IAA and I-gly are observed as the major 
metabolites. T-NH2 and urea overlapped in the effluent from both of the 
columns. 
In the normal rat.--In this experiment, ten metabolites were 
isolated and identified as urea, T-NH2, Kyn, Try, N-A-Kyn, N-A-OH-Kyn, 
IAA,·I-gly,. I-ald·and K. A. as shown .. inFigures 17and 18.and Table I. 
Of interest is the fact that the excretion of I-gly by the vitamin 
86-deficient animal, after the administration of D-tryptophan, is 
higher than that of IAA; the reverse is observed in the B6-fed anima 1. 
Moreover, I-ald is confirmed as one of the major metabolites of D-
tryptophan excreted by the rat. No vitamin 86 effect on the formation 
of this indole compound was observed. 
Metabo 1 ites of L-Tryptophan in Bfi-Fed Anima 1 s 
In the germ-free rat.--Six metabolites were isolated and identified 
as urea, K. A., N-A-Kyn, N-A-OH-Kyn, IAA and I-gly (Figures 19 and 20 
and Table III). The excretion of IA~ and I-gly was much less in this 
run as compared to that from the animals injected with D-tryptophan. 
I-ald was not detected in this experiment. The qua·ntitative data are 
summarized in Table III. 
Figure 17. 
Figure 18. 
Separation of Urinary Tryptophan 
Metabolites of B6-Deficient Rat 
Injected with D-Tryptophan-
Methylene-14C on the pH 4.0 DEAE-
Cellulose Column. 
Rechromatography of Combined Fractions 
14-35 from the pH 4.0 Column (Figure 17) 
on the pH 8.0 DEAE-Cellulose Column. 
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Separation of Urinary Tryptophan 
Metabolites of Germ-Free Rat 
Injected with L-Tryptophan-
Methylene-14C on the pH 4.0 DEAE-
Cellulose Column. 
Rechromatography of Combined Fractions 
13-35 from the pH 4.0 Column (Figure 19) 
on the pH 8.0 DEAE-Cellulose Column. 
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TABLE II I 
DISTRIBUTION OF RADIOACTIVITY AMONG METABOLITES IN 24-HOUR URINE 
SAMPLES OF NORMAL AND B5-DEFICIENT RATS FOLLOWING 
THE INTRAPERITONEAL INJECTION OF 17 MG/lOOG 
L-TRYPTOPHAN-METHYLENE- 14C (% OF DOSE) 
Metabolites 
co2 output 








Kynureni c acid 
Xanthurenic acid 



























































In the normal rat.--The urinary metabolites of this experiment are 
the same as those from the germ-free rat. However, only a trace of 
K. A. was observed in this experiment. Again, a conspicuous amount of 
N-A-Kyn and N-A-OH-Kyn was observed as compared to that in the germ-free 
animal. The separation pattern of the urinary radioactive metabolites 
is shown in Figures 21 and 22. 
Metabolites of L-Tryptophan in 85-Deficient Animals 
A remarkable difference between the metabolism .of B6-fed and B6-
defi ci ent animals after administration of L-tryptophan was observed. 
In the germ-free raL--A large quantity of OH-Kyn and X. A. was 
isolated. The separation pattern in the dual column chromatography 
system is shown in Figures 23 and 24. The X. A. conjugate compound 
(B6GFL8 of Figure 23, Unknown I) was also observed. The excretion of 
N-A-Kyn and N-A .. QH-Kyn is strikingly larger than that from B6-fed 
animals after administration of L-tryptophan. The absence of IAA and 
I-gly is worthy of note. Several metabolites, including B6GFL1c of 
Fiij.ure 24, B6GFL7 ,8,9 of Figure 23, have not been identified as yet. 
The properties of a6GFL7 and B6GFL9 are given in Table IV. 
The properties of B6GFL7 are the same as those of B6GFD9 (Figure 
14) which was isolated from the urine of the germ-free rat injected with 
D-tryptophan. The migration properties of the metabolites, B6GFL7 
(B6GFD9) and B6GFL9, on paper chromatography are distinctly different 
from those which have been reported so far for the metabolites of 
tryptophan and the metabolites of X. A. and quinaldic acid (134, 135, 
136). 
In the normal rat.--A similarity in the metabolism of the germ-free 
Figure 21, 
Figure 22. 
Separation of Urinary Tryptophan 
Metabolites of Normal Rat Injected 
with L-Tryptophan-Methylene- 14C on 
the pH 4,0 DEAE-Cellulose Column. 
Rechromatography of Combined Fractions 
14-30 from the pH 4,0 Column (Figure 21) 
on the pH 8.0 DEAE-Cellulose Column, 
64 
pH4,0 TEA-F 14 pH 4.o TEA:...F: i l!IM(2.SOmi) 1 0~1 M(250ml), 4 ml each ~· 
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TEA-F 17 mM, 
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Separation of Urinary Tryptophan 
Metabolites of B6-Deficient Germ-
Free Rat Injectea with L-Tryptophan-
Methylene-14C on the pH 4.0 DEAE-
Cellulose Column. 
Rechromatography of Combined Fractions 
13-30 from the pH 4.0 Column (Figure 23) 
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PROPERTIES OF B6GFL7* (OR B6GFD9#) AND B6GFL9* 
B6GFL7 B6GFL9 
Rf in BuOH-HAc-H20 
( 4: 1 : 5 by VO 1) 0.15-0.22 0.20-0.22 
Rf in 20% (w/v) KCl Q.90-0.94 0.40-0.42 
Ehrlich I s reagent test Negative Negative 
Ninhydri n test Negative Negative 
Fluorescence Light Blue Light Blue 
*The metabolites were isolated from the urine of B6-deficient germ-
free rat injected with L-tryptophan. 
#The metabolite was isolated from the urine of B6-deficient germ-
free rat injected with D-tryptophan. 
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and normal animals, those that were under B6-depletion and loaded with 
L-tryptophan, was observed. However, in this experiment, a significant 
excretion of X. A., OH-Kyn, K. A., Kyn, N-A-Kyn and N-A-OH-Kyn was 
observed (Figures 25 and 26). IAA and I-gly were not detected. The 
X. A. conjugate compound (Unknown I) was also observed (B6LN7 in Figure 
25), 
Urinary Metabolites of Indoleacetic Acid-2-14c in s6-Fed 
and B6-Deficient Animals 
Since I-ald has been reported as an end product from tryptophan 
through the intermediate, IAA, by the action of oxidase in plants (61, 
62, 63, 64), this experiment was intended to determine if IAA is the 
precursor of I-ald in the mammal. The data suggest that I-ald is not 
derived from IAA in the rat. 
In the normal rat.--Of the injected radioactivity 96% was excreted 
in the urine, 51% of the total dose remained as the original form, IAA, 
and 45% was conjugated with glycine as indoleaceturic acid (I-gly) 
(Figure 27). I-ald was not detected in the urine. 
In the 86-deficient rat.--It was surprising that 85% of the 
injected IAA-14c was isolated as I-gly, and only 6% of the total dose 
remained as IAA (Figure 28). Moreover, I-ald was not detected. 
Figure 25. Separation of Urinary Tryptophan 
Metabolites of B6-Deficient Rat 
Injected with L-Tryptophan-
Methylene-14C on the pH 4.0 DEAE-
Cellulose Column. 
Figure 260 Rechromatography of Combined Fractions 
15-30 from the pH 4.0 Column (Figure 25) 
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Figure 27, Separation of Urinary lndole-3-Acetic 
Acid Metabo 1 i tes of Norma 1 Rat Injected 
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Figure 28, Separation of Urinary Indole-3-Acetic 
Acid Metabolites of 86-Deficient Rat 
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Very little was known about the mammalian formation from tryptophan 
of IAA and related indole compounds when this study was initiated. 
Indeed, only a few reports suggesting the possible pathways for the 
formation of IAA had appeared. Weissbach et al. (10) reported that the 
excretion of IAA was increased markedly by L-tryptophan loading. Most 
qf the IAA which was formed by-mammalian tissues i!!_ vitro arose through 
transami,nati on involving a.-ketogl utarate and pyri doxa l phosphate. 
Mamma 1 i an kidney ancl 1 i ver were both found to be capabl'e of decarboxy-
1 ating L-tryptophan to yield tryptamine. · However, the bulk of IAA was 
presumed to arise from transamination, with smaller amounts arising 
through decarboxylation. 
Since a satisfactory separation technique for urinary indole com-
pounds was not available before this study was initiated, it was first 
necessary to develop a convenient and reliable method for isolating the 
radioactive metabolites of tryptophan from the urine. A DEAE-cellulose 
dual column chromatography system was developed. 
The data summarized in Tables I and III demonstrate that D-
tryptophan is a more efficient precursor of IAA than is L-tryptophan. 
In the germ-free and the normal rats after administration of L-
tryptophan, the excretion of IAA and I-gly total 0.9% and 0.9% of the 
total dose, respectively. On the other hand, 12.8% and 6.3% of IAA 
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and I-gly are excreted from germ-free and normal rats after administra-
tion of 0-tryptophan, The transformation of L-tryptophan into IAA was 
blocked by vitamin B6-deficiency. However, the result indicated that 
vitamin B5 was not required for this transformation from 0-tryptophan; 
14.3% and 5,8% of the total dosage are excreted from the germ-free and 
the normal rats after injection of 0-tryptophan to vitamin B5-deficient 
rats, It is obvious that the mechanism of formation of IAA from D-
tryptophan must differ from that of IAA from L-tryptophan in rats. 
It is worthy of note that excretion of indole-3-carboxaldehyde 
either from the vitamin B6-fed or from the vitamin B6-deficient animals 
injected with 0-tryptophan was observed. A 1 so, vitamin B5 seems to 
have no effect on the formation of indole-3-carboxaldehyde; in g,erm-
free animals l,9% of the injected dose in the B6-fed and 6.1% in the B6-
deficient animals were excreted as I-ald; in normal animals, 5,4% in the 
B6-fed and 1.7% in the B5-deficient animals were excreted as I-ald. 
However, the excretion of this substance was not observed in either 
vitamin B6-fed or B6-deficient animals after the administration of L-
tryptophan. 
The experimental results indicate that both IAA and I-ald are 
formed without any effect of pyridoxine from 0-tryptophan. Two possi-
ble pathways leading to these indole compounds from 0-tryptophan can be 
postulated as shown in Figure 29. In one pathway, 0-tryptophan is 
deaminated by 0-amino acid oxidase to indolepyruvic acid, followed by 
decarboxylation to indoleacetaldehyde which is converted to IAA and 
I-ald. The decarboxylation step is not significantly decreased in 
vitamin B6 deficiency, Another possible path is from D-tryptophan via 
the intermediate, tryptamine, which is formed without serious 
Figure 29. Possible Pathways for the Biosynthesis 
of Indole-3-Acetic Acid and Indole-3-
Carboxa l dehyde. 
The reactions indicated are: (1) decarboxylation; 
(2) oxidative qeamination; (3) transamination; 
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indole-3-acetic acid · indole-3-carboxaldehyde 
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limitation in B6 deficiency by decarboxylation. The finding of 
tryptamine in the urine of B6-deficient animals may support this hypoth-
esis. 
It is well known that indolealkylamines which are substrates of 
monoamine oxidase yield the corresponding indoleacetic acids as their 
final metabolic products. The whole process (137, 138) comprises two 
steps: In the first, initiated by monoamine oxidase, the amine under-
goes oxidative deamination to the aldehyde, and in the second, cata-
lyzed by aldehyde dehydrogenase, the intermediate aldehyde is oxidized 
to the acid. 
Very recently, Keglevic et al. (139) proposed a pathway for the 
formation of 5-hydroxyindoleacetic acid and 5-hydroxyindole-3-
carboxaldehyde from 5-hydroxytryptamine (serotonin) .. They reported 
that the intermediate, 5-hydroxyindoleacetaldehyde, is not stable 
enough to permit isolation and purification from biological materials. 
Indeed, the existence.of 5-hydroxyindoleacetaldehyde as an intermediate 
in serotonin metabolism has been unequivocally established (107, 140) 
using a trapping technique for its detection. Hence, indoleacetalde-
hyde is most likely an intermediate on the pathway leading to !AA and 
I-ald. 
The interference of vitamin B6-deficiency in the formation of 
indole compounds from L-tryptophan is consistent with- the report of 
Weissbach et al. (10). However, the data presented in the thesis do not 
establish whether the pathway leading to IAA from L-tryptophan proceeds 
via indolepyruvic acid, or whether L-tryptophan is converted to D-
tryptophan prior to further metab·o l ism, or both. 
It is worthy of mention that Wightman (70) summarized some possible 
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pathways involved in the biogenesis of simple indole compounds from OL-
tryptophan-methylene-14c in cabbages as shown in Figure 1. He 
suggested that indole-3-acetonitrile was a central intermediate leading 
to IAA and I-ald, and that indolepyruvate was not confirmed as an 
intermediate. His report is partially consistent with the findings of 
this thesis. Since in Wightman's experiment, OL-tryptophan-methylene-
14c was used as the precursor of IAA and the indole compounds, it is 
. .... .. 
possib"le that the IAA, I-ald and related indole compounds may have been 
derived chiefly from 0-tryptophan, not from L-tryptophan. 
The existence of the pyrrolase metabolic pathway for 0-tryptophan 
seems to be indisputable. Indeed, the enzyme which converts 0-
tryptophan to 0-kynurenine has been reported by several workers (28, 
29). However, our data show that N-A-Kyn and N-A-OH-Kyn are common 
excretory metabolites from both 0- and L-tryptophan. However, no 86 
effect on their formation was observed in 0-tryptophan metabolism, in 
contrast to an increase of these two metabolites following L-tryptophan 
administration in vitamin B6-deficiency. 
However, the metabolism of 0- and L-tryptophan is significantly 
different (see Tables I and III). In L-tryptophan metabolism, the 
pyrrolase metabolic pathway seems to be the major route; on the con-
trary, the pathway leading to the formation of IAA and the related 
indole compounds is the major one in 0-tryptophan metabolism. Follow-
ing L-tryptophan administration, a significant increase in the excre-
tory metabolites, such as OH-Kyn; K. A. N-A-Kyn, N-A-OH-Kyn, X. A. 
and the xanthurenic acid conjugate (Unknown I), is observed in the 
pyridoxine-deficient animals. These findings are in agreement with 
previous reports (112, 113, 114). 
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In 1954, Christensen et al. (117) reported that the uptake of 
glycine, L-tryptophan and L-methi oni ne into the animal cells was 
decreased by vitamin B6-depletion. In the experiments with IAA-2-1 4c 
administration, 85% of the total dose was isolated from the vitamin B6-
deficient animal as excretory I-gly. This result could be explained by 
the findings of Christensen et al, if, in the pyridoxine-deficient 
condition, the glycine transport into most cells is inhibited, but not 
that into the cells in which I-gly is formed, thus allowing greater 
availability of glycine to conjugate with IAA. The ratio of excretory 
IAA and I-gly from various experimental animals. (Table V) can provide 
the evidence to support this hypothesis, 
Finally, the lack of formation of I-ald from IAA may be explained 
in two ways. First, IAA is not a precursor of I-ald in mammalian 
metabolism. Second, IAA may not be effectively transported into the 
cell, in which I-ald is formed and thus I-ald is not observed. 
TABLE V 
RATIO OF RADIOACTIVITY IN INDOLEACETIC ACID/lNDOLEACETURIC ACID IN 
URINE EXCRETED BY NORMAL AND B6-DEFICIENT RATS FOLLOWING THE 
INTRAPERITONEAL INJECTION OF INDOLEACETIC ACID-
2-14C, L- AND D-TRYPTOPHAN-METHYLENE-14C 
Germ-free Normal 
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Compound injected B6-fed B6-def B6-fed B6-def 
.Indoleacetic acid 1.1 0.07 
D-Tryptophan 1.5 0.6 1.5 0. 5 
L-Tryptophan 2.0 * 2.0 * 
*Indoleacetic acid and indoleaceturic acid were not found. 
SUMMARY 
A DEAE-cellulose dual column chromatography system was developed to 
separate tryptophan metabolites. A previously unreported urinary 
metabolite of tryptophan, indole-3-carboxaldehyde was isolated and 
identified from the urine of normal, vitamin 85-deficient, germ-free 
and vitamin s6-deficient germ-free rats following intraperitoneal 
injection of D-tryptophan-methylene-14c. This new metabolite was not 
detected from the urine of rats injected with either L-tryptophan-
methylene-14c or indoleacetic acid-2-14c. The pyridoxine-deficient 
rats, after administration of L-t~yptophan-methylene-14c, excreted 
abnormally large quantities of 3-hydroxykynurenine, kynurenic acid, 
N-acetylkynurenine, N-acetyl-3-hydroxykynurenine, xanthurenic acid and 
a conjugate compound of xanthurenic acid in contrast with the lack of 
formation of indoleacetic acid and indoleaceturic acid. On the con-
trary, no significant effect of vitamin 85-deficiency was observed in 
the metabolism of 0-tryptophan. 
The experimental data suggest: 
1) Indoleacetic acid and indole-3-carboxaldehyde are mainly de-
rived from D-tryptophan in mammals. The pathways leading to these 
indole compounds can be postulated as proceeding either via decarboxy-
lation to form tryptamine as the precursor of the central intermediate, 
indoleacetaldehyde, which leads to indoleacetic acid and indole-3-
carboxaldehyde, or by oxidative deamination to indolepyruvic acid 
followed by decarboxylation to indoleacetaldehyde as the precursor of 
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indoleacetic acid and indole-3-carboxaldehyde. 
2) The pathway leading to indoleacetic acid from L-tryptophan may 
be either via transamination to form indolepyruvic acid or conversion 
to D-tryptophan prior to further metabolism. 
3) The metabolism of D-tryptophan and L-tryptorhan is siqnifi-
cantly different. In L-tryptophan metabolism, the pyrro 1 ase metabolic 
pathway seems to be the major route, on the contrary, the pathway 
leading to indoleacetic acid and related indole compounds seems to be 
the major one in D-tryptophan metabolism. 
4) The lack of formation of indole-3-carboxaldehyde from indole-
acetic acid in rats may be explained in two ways, First indoleacetic 
acid is not a precursor of indole-3~carboxaldehyde in mammalian 
i 
metabolism. Second, indoleacetic acid may not be effectively trans-
ported into the cell, and thus indole-3-carboxaldehyde formation is 
not observed. 
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